USPTO serial 99686197
AQUALINK
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- MICHOS, JOHN E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with AQUALINK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christopher D Olszyk, Jr.
Christopher D Olszyk, Jr. Fox Rothschild LLP212 Carnegie Center, Suite 400Princeton, NJ 08540United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical substances for use in the connection of small and large molecules to antibodies for use in scientific and medical research; Chemical, biochemical and biological reagents for scientific or medical research use; Diagnostic preparations for scientific and medical research use in the field of antibody conjugates for scientific and medical research; Hydrophilic chemical connectors for scientific purposes, other than for medical or veterinary purposes; Biologics, namely, antibodies used to covalently attach a small or large molecule to an antibody, for scientific and medical research; Biologics, namely, antibodies incorporating hydrophilic chemical connectors for use in covalently attaching a small or large molecule to an antibody, for scientific and medical research. | ACTIVE | — |
| 005 | Diagnostic preparations, namely, antibodies incorporating hydrophilic chemical connectors for use in covalently attaching a small or large molecule to an antibody, for medical diagnosis and treatment purposes; Delivery agents for antibodies, namely, drug delivery agents in the form of hydrophilic chemical connectors that facilitate the delivery and action of medical preparations; Diagnostic preparations, namely, hydrophilic chemical connectors for use in covalently attaching a small or large molecule to an antibody, for use in the fields of medical diagnosis and treatment; Chemical, biological and biochemical preparations for medical and pharmaceutical use, namely, hydrophilic chemical connectors for medical diagnosis and treatment in the fields of cancer, inflammatory disease, infectious disease and neurologic diseases and disorders; Pharmaceutical preparations and diagnostic preparations medical articles, namely, hydrophilic chemical connectors for medical diagnosis and disease treatment in the fields of cancer, inflammatory disease, infectious disease and neurologic diseases and disorders. | ACTIVE | — |
| 042 | Research and development of hydrophilic chemical connectors; Scientific research for medical purposes in the field of cancer, inflammatory disease, infectious disease and neurologic diseases and disorders; Research and development services in the field of antibodies; Antibody engineering; Custom design and engineering of antibodies; Research and development of pharmaceuticals for the treatment of cancer, inflammatory disease, infectious disease and neurologic diseases and disorders; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Research, development and establishment of testing specifications and procedures in the fields of cancer, inflammatory disease, infectious disease and neurologic diseases and disorders research, diagnosis and treatment; Providing scientific research information in the fields of cancer, inflammatory disease, infectious disease and neurologic diseases and disorders research, diagnosis and treatment; Scientific and technological services and research relating thereto, namely, research, analysis and testing in the fields of antibodies, antibody conjugates, and hydrophilic chemical connectors | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Aarvik Therapeutics, Inc.
- Other trademarks owned by Aarvik Therapeutics, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named AQUALINK
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 13, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 13, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 7, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 17, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 10, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 10, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 10, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 16, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 16, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 16, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 15, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 15, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 6, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 6, 2026 | NWAP | NEW APPLICATION ENTERED | — |